Heggestad Mark A 4
4 · AMERICAN MEDICAL SYSTEMS HOLDINGS INC · Filed Jun 21, 2011
Insider Transaction Report
Form 4
Heggestad Mark A
Exec. VP and CFO
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2011-06-17−60,000→ 0 totalExercise: $10.82Exp: 2016-02-09→ Common stock (60,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−40,000→ 0 totalExercise: $14.36Exp: 2015-03-05→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−59,350→ 0 totalExercise: $20.05Exp: 2018-02-10→ Common Stock (59,350 underlying) - Disposition to Issuer
Common Stock
2011-06-17−9,506→ 0 total - Disposition to Issuer
Common Stock
2011-06-17−12,672→ 9,506 total - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−175,000→ 0 totalExercise: $18.75Exp: 2013-12-17→ Common Stock (175,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−15,977→ 47,933 totalExercise: $18.46Exp: 2017-02-11→ Common Stock (15,977 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−47,933→ 0 totalExercise: $18.46Exp: 2017-02-11→ Common Stock (47,933 underlying)
Footnotes (8)
- [F1]Pursuant to the merger of a wholly-owned subsidiary of Endo Pharmaceutials Holdings Inc. ("Endo") with and into American Medical Systems Holdings, Inc. (the "Merger"), such shares were disposed of in exchange for $380,160 in cash.
- [F2]These restricted shares were assumed by Endo in the Merger in exchange for 7,181 restricted shares of Endo common stock, having a market value of $38.32 per share on the effective date of the Merger. The vesting terms of the new Endo restricted stock grants will remain the same as the vesting terms of the old grants.
- [F3]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $1,968,750 representing the difference between the exercise price of the option and the $30.00 per share price.
- [F4]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $625,800 representing the difference between the exercise price of the option and the $30.00 per share price.
- [F5]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $1,150,500 representing the difference between the exercise price of the option and the $30.00 per share price.
- [F6]This option, which vested with respect to 25% of the shares on March 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was canceled with respect to 15,977 shares in the Merger in exchange for a cash payment of $184,374.58 representing the difference between the exercise price of the option and the $30.00 per share price.
- [F7]This option, which vested with respect to 25% of the shares on March 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 36,213 shares of Endo common stock with an exercise price of $24.44 per share.
- [F8]This option, which vested with respect to 25% of the shares on March 31, 2012 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 44,838 shares of Endo common stock with an exercise price of $26.54 per share.